These data suggest that the enhanced tumor growth in Dnase1l3-deficient mice might be a result of impaired DC function and consequent reduction in cytotoxic CD8+ and CD4+ T cells in dLNs and tumors. This evidence concerns the gene DNASE1L3 and neoplasm.